OTTAWA – A new study finds that patients treated for mental illness in Canada are waiting far too long to get drug approval and face inequitable access across the country. The Mood Disorders Society of Canada’s study, System Broken, finds that Canadians who rely on public drug plans are at a particular disadvantage. As we …
Pictured: A woman scratches skin lesions on her elbow/iStock, helivideo The FDA on Wednesday approved UCB’s bimekizumab for the treatment of adults with moderate to severe plaque psoriasis. The treatment will be sold under the Bimzelx brand. Bimzelx is a humanized IgG1 monoclonal antibody that acts by targeting IL-17A and IL-17F, two central players in …
A new drug intended to treat a type of inflammatory bowel disease (IBD) has received the green light from the Food and Drug Administration. The FDA on Friday approved Pfizer’s etrasimod, branded as Velsipity, to treat adults with a chronic digestive disorder known as ulcerative colitis (UC). The oral pill, taken once a day, was …